title: Discontinuation rate of nevirapine-based highly active antiretroviral therapy.
authors.forename: Miguel
authors.initials: M
authors.lastname: Górgolas
authors.forename: Cristina
authors.initials: C
authors.lastname: Hidalgo
authors.forename: Frances
authors.initials: F
authors.lastname: Williams
authors.forename: Manuel Fernández
authors.initials: MF
authors.lastname: Guerrero
mesh_terms: D000328:Adult; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects; D018791:CD4 Lymphocyte Count; D056486:Chemical and Drug Induced Liver Injury / Q000453:epidemiology*; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology*; D006801:Humans; D008297:Male; D019829:Nevirapine / Q000008:administration & dosage* / Q000009:adverse effects*; D012307:Risk Factors; D028761:Withholding Treatment
chemical_list: D019829:Nevirapine